| Targeting and crossing the blood-brain barrier with extracellular vesicles J Saint-Pol, F Gosselet, S Duban-Deweer, G Pottiez, Y Karamanos Cells 9 (4), 851, 2020 | 332 | 2020 |
| Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer’s disease JA Loureiro, S Andrade, A Duarte, AR Neves, JF Queiroz, C Nunes, ... Molecules 22 (2), 277, 2017 | 284 | 2017 |
| PECAM-1 stabilizes blood-brain barrier integrity and favors paracellular T-cell diapedesis across the blood-brain barrier during neuroinflammation I Wimmer, S Tietz, H Nishihara, U Deutsch, F Sallusto, F Gosselet, R Lyck, ... Frontiers in immunology 10, 447986, 2019 | 165 | 2019 |
| Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P … P Candela, F Gosselet, J Saint-Pol, E Sevin, MC Boucau, E Boulanger, ... Journal of Alzheimer's Disease 22 (3), 849-859, 2010 | 162 | 2010 |
| Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro P Candela, F Gosselet, F Miller, V Buee-Scherrer, G Torpier, R Cecchelli, ... Endothelium 15 (5-6), 254-264, 2008 | 125 | 2008 |
| Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment MJ Ramalho, E Sevin, F Gosselet, J Lima, MAN Coelho, JA Loureiro, ... International journal of pharmaceutics 545 (1-2), 84-92, 2018 | 123 | 2018 |
| Cyclodextrins as emerging therapeutic tools in the treatment of cholesterol-associated vascular and neurodegenerative diseases C Coisne, S Tilloy, E Monflier, D Wils, L Fenart, F Gosselet Molecules 21 (12), 1748, 2016 | 122 | 2016 |
| Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes E Vandenhaute, L Dehouck, MC Boucau, E Sevin, R Uzbekov, M Tardivel, ... Current neurovascular research 8 (4), 258-269, 2011 | 106 | 2011 |
| Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood–brain barrier: use of an in vitro model F Gosselet, P Candela, E Sevin, V Berezowski, R Cecchelli, L Fenart Brain research 1249, 34-42, 2009 | 96 | 2009 |
| Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro H Nishihara, S Soldati, A Mossu, M Rosito, H Rudolph, WA Muller, ... Fluids and Barriers of the CNS 17, 1-18, 2020 | 78 | 2020 |
| Evaluation of drug-induced neurotoxicity based on metabolomics, proteomics and electrical activity measurements in complementary CNS in vitro models L Schultz, MG Zurich, M Culot, A da Costa, C Landry, P Bellwon, T Kristl, ... Toxicology in Vitro 30 (1), 138-165, 2015 | 78 | 2015 |
| Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier F Gosselet, J Saint-Pol, P Candela, L Fenart Current Alzheimer Research 10 (10), 1015-1033, 2013 | 77 | 2013 |
| Efficient docosahexaenoic acid uptake by the brain from a structured phospholipid M Hachem, A Géloën, AL Van, B Foumaux, L Fenart, F Gosselet, ... Molecular neurobiology 53, 3205-3215, 2016 | 75 | 2016 |
| Effects of oxysterols on the blood–brain barrier: Implications for Alzheimer’s disease F Gosselet, J Saint-Pol, L Fenart Biochemical and biophysical research communications 446 (3), 687-691, 2014 | 75 | 2014 |
| HIV neuroinfection and Alzheimer’s disease: similarities and potential links? G Canet, C Dias, A Gabelle, Y Simonin, F Gosselet, N Marchi, A Makinson, ... Frontiers in cellular neuroscience 12, 307, 2018 | 74 | 2018 |
| A silicon nanomembrane platform for the visualization of immune cell trafficking across the human blood–brain barrier under flow A Mossu, M Rosito, T Khire, H Li Chung, H Nishihara, I Gruber, E Luke, ... Journal of Cerebral Blood Flow & Metabolism 39 (3), 395-410, 2019 | 72 | 2019 |
| Central nervous system delivery of molecules across the blood-brain barrier F Gosselet, RA Loiola, A Roig, A Rosell, M Culot Neurochemistry international 144, 104952, 2021 | 71 | 2021 |
| Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation J Saint-Pol, E Vandenhaute, MC Boucau, P Candela, L Dehouck, ... Journal of Alzheimer's Disease 30 (3), 489-503, 2012 | 69 | 2012 |
| BMP2 and BMP6 control p57Kip2 expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes FP Gosselet, T Magnaldo, RM Culerrier, A Sarasin, JC Ehrhart Cellular signalling 19 (4), 731-739, 2007 | 69 | 2007 |
| UVB-induced mutations in human key gatekeeper genes governing signalling pathways and consequences for skin tumourigenesis JC Ehrhart, FP Gosselet, RM Culerrier, A Sarasin Photochemical & Photobiological Sciences 2 (8), 825-834, 2003 | 67 | 2003 |
